Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 34% ± 12% | |
| B cell | 3 studies | 20% ± 3% | |
| endothelial cell | 3 studies | 20% ± 3% | |
| ciliated cell | 3 studies | 23% ± 4% | |
| dendritic cell | 3 studies | 22% ± 2% | |
| goblet cell | 3 studies | 20% ± 4% | |
| basal cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 789.85 | 459 / 459 | 100% | 11.36 | 1118 / 1118 |
| esophagus | 100% | 720.66 | 1445 / 1445 | 100% | 11.29 | 183 / 183 |
| ovary | 100% | 712.39 | 180 / 180 | 100% | 8.34 | 429 / 430 |
| stomach | 100% | 723.71 | 359 / 359 | 100% | 11.30 | 285 / 286 |
| lung | 99% | 603.34 | 575 / 578 | 100% | 10.55 | 1155 / 1155 |
| intestine | 100% | 897.22 | 966 / 966 | 99% | 11.00 | 524 / 527 |
| brain | 100% | 504.99 | 2630 / 2642 | 100% | 8.58 | 704 / 705 |
| uterus | 100% | 765.03 | 170 / 170 | 99% | 11.45 | 455 / 459 |
| prostate | 100% | 842.95 | 245 / 245 | 99% | 7.12 | 497 / 502 |
| pancreas | 100% | 462.12 | 328 / 328 | 99% | 8.29 | 176 / 178 |
| bladder | 100% | 771.05 | 21 / 21 | 99% | 8.91 | 498 / 504 |
| thymus | 100% | 840.68 | 653 / 653 | 98% | 5.61 | 591 / 605 |
| liver | 100% | 630.39 | 226 / 226 | 97% | 7.29 | 392 / 406 |
| skin | 100% | 840.98 | 1809 / 1809 | 94% | 7.79 | 446 / 472 |
| kidney | 100% | 573.71 | 89 / 89 | 91% | 4.63 | 816 / 901 |
| adrenal gland | 100% | 788.62 | 258 / 258 | 83% | 3.41 | 191 / 230 |
| adipose | 100% | 759.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.55 | 29 / 29 |
| spleen | 100% | 1015.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 9.78 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.51 | 1 / 1 |
| blood vessel | 100% | 565.96 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 527.92 | 797 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 421.85 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 76% | 454.31 | 710 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 60% | 2.53 | 48 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042274 | Biological process | ribosomal small subunit biogenesis |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005694 | Cellular component | chromosome |
| GO_0032040 | Cellular component | small-subunit processome |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | C1orf131 |
| Protein name | Chromosome 1 open reading frame 131 Uncharacterized protein C1orf131 |
| Synonyms | hCG_14915 cPERP-A |
| Description | FUNCTION: Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Prevents helicase DHX37 to be recruited before post-A1 state. . |
| Accessions | ENST00000366649.7 [Q8NDD1-1] Q5TBI2 ENST00000451322.1 ENST00000318906.6 ENST00000366651.7 [Q8NDD1-6] Q8NDD1 Q5TBH9 |
